Skip to content

Course home

Sign up

6.3 Monitoring and maintaining health

EasyMediumHard
1234567891011121314151617181920212223242526272829303132333435363738
Question 7

The table below is used to estimate a person's Metabolic Health Risk Index (MHRI). The higher a person's total point score, the greater their risk of developing metabolic complications.

Risk factor1 point2 points3 points
Average daily sleepMore than 7 hours5–7 hoursLess than 5 hours
Daily refined sugar intakeUnder 25 g25–50 gOver 50 g
Cardio exercise (minutes/week)More than 150 mins60–150 minsLess than 60 mins
Waist-to-Height Ratio (WHtR)Under 0.450.45–0.55Over 0.55
Direct relatives with Type 2 Diabetes012 or more
a.

According to the table, how many points are scored by a person whose cardio exercise is 50 minutes per week?

[1]
b.

What is the effect of a higher Waist-to-Height Ratio (WHtR) on the Metabolic Health Risk Index (MHRI)?

[1]
c.

Here is some information about two patients:

  • Patient A:

    • Sleeps 4.5 hours per day on average
    • Daily refined sugar intake: 60 g
    • Cardio exercise: 180 minutes per week
    • WHtR: 0.52
    • 0 direct relatives with Type 2 Diabetes
  • Patient B:

    • Sleeps 6 hours per day on average
    • Daily refined sugar intake: 35 g
    • Cardio exercise: 100 minutes per week
    • WHtR: 0.56
    • 1 direct relative with Type 2 Diabetes

Use the table to calculate whether Patient A or Patient B has a higher risk of developing metabolic complications. Show how you worked out your answer.

[4]
Markscheme

6.3 Monitoring and maintaining health Questions

  1. GCSE
  2. /Biology
  3. /6.3 Monitoring and maintaining health

97 exam-style questions on OCR GCSE Biology 6.3 Monitoring and maintaining health, covering 6.3.1 Health and disease, 6.3.2 Interactions between diseases, 6.3.3 Spread of communicable diseases, 6.3.4 Common infections and diseases, 6.3.5 Physical plant defence responses, 6.3.6 Chemical plant defence responses, 6.3.7 Detecting and identifying plant diseases, 6.3.8 White blood cells and platelets, 6.3.9 Non-specific defence systems, 6.3.10 The immune system, 6.3.11 Monoclonal antibodies, 6.3.12 Vaccines and medicines, 6.3.13 Aseptic techniques, 6.3.14 Discovery and development of new medicines, 6.3.15 Causes of non-communicable diseases, 6.3.16 Treatments for cardiovascular disease, 6.3.17 Lifestyle factors and non-communicable diseases, 6.3.18 Cancer, 6.3.19 Stem cells in medicine, 6.3.20 Gene technology in medicine, and 6.3.21 The human genome and medicine. Each one has a worked solution and a mark scheme showing where the marks go.

Question bank